National Institute for Health and Care Excellence
Non-departmental public body of the Department of Health in the UK
Follow National Institute for Health and Care Excellence on Notably News to receive short updates to your email — rarely!
| 2022 | PricewaterhouseCoopers conducted a study for the Association of the British Pharmaceutical Industry, examining 13 medicines recommended by NICE for various conditions and revealing that 1.2 million patients had not received potentially beneficial drugs. |
| 2021 | NICE published new guidelines for ME/CFS, which were criticized by the Royal College of Physicians and 49 academics for not properly evaluating or recommending graded exercise therapy and cognitive behavioral therapy. |
| 2016 | NHS England planned to fund 10,000 courses of hepatitis C treatment through 22 Operational Delivery Networks, with patients with cirrhosis or fibrosis given priority. |
| 2015 | NICE approved sofosbuvir, a new oral therapy for hepatitis C, which costs approximately £30,000 for a 12-week treatment course. |
| February 2015 | A report from the University of York Centre for Health Economics by Karl Claxton suggested reducing the cost-effectiveness threshold for medicines from £30,000 to £13,000 per quality-adjusted life year. |
| October 2014 | Andy Burnham proposed that a Labour government could make NICE clinical guidelines mandatory for commissioners, suggesting strengthening NICE's role in ensuring consistent access to recommended drugs and procedures. |
| 2011 | The Cancer Drugs Fund was established in response to complaints about NICE decisions on new and expensive cancer drugs with limited benefits. |
This contents of the box above is based on material from the Wikipedia article National Institute for Health and Care Excellence, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.